Table 3.
Hemophilia | Inhibitor | aPL | Warfarin | Anti-Xa | PW | TP | DIC | ||
---|---|---|---|---|---|---|---|---|---|
Second derivative | Time | Long | Long | Long | ND | Slightly long | ND | ND | Long |
Height | Low | Significantly low | Low | ND | Slightly low | High | Slightly high | Low | |
Wide | Long | Long | Long | ND | Slightly long | ND | ND | Slightly long | |
First derivative | Time | Long | Significantly long | Long | ND | Slightly long | ND | ND | Long |
Height | Slightly low | Significantly low | Slightly low | ND | High | High | ND | Low | |
Fibrin formation | Height | High | High | High | High | High | High | High | High |
Time | Long | Significantly long | Long | ND | Slightly long | ND | ND | Long |
Abbreviations: aPL, patients positive for antiphospholipid antibody; DIC, disseminated intravascular coagulation; mAbs, m-absorbance; PW, pregnant women; TP, thrombophilia; Warfarin, patients treated with warfarin, Anti-Xa, patients treated with anti-Xa agent.